Innovations in Psoriatic Arthritis Treatments

This chapter explores the latest advancements in treatment options for psoriatic arthritis and axial spondyloarthritis, focusing on the efficacy of bemikizumab and sonolocumab. It discusses phase two trial results that highlight significant patient response improvements and the challenges of differentiating between the increasing number of IL-17 inhibitors.